These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 30371509)
1. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas. Tian X; Xu J; Dorfman DM Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas. Tian X; Pelton A; Shahsafaei A; Dorfman DM Mod Pathol; 2016 Sep; 29(9):1050-7. PubMed ID: 27282353 [TBL] [Abstract][Full Text] [Related]
3. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Moore EM; Swerdlow SH; Gibson SE Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661 [TBL] [Abstract][Full Text] [Related]
4. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities. Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074 [TBL] [Abstract][Full Text] [Related]
5. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma. Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177 [TBL] [Abstract][Full Text] [Related]
6. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features. Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761 [TBL] [Abstract][Full Text] [Related]
7. Atypical variants of nodular lymphocyte-predominant Hodgkin lymphoma show low microvessel density and vessels of distention type. Scheidt V; Hansmann ML; Schuhmacher B; Döring C; Hartmann S Hum Pathol; 2017 Feb; 60():129-136. PubMed ID: 27816718 [TBL] [Abstract][Full Text] [Related]
8. EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features. Liu Y; Yu K; Li M; Zeng K; Wei J; Li X; Liu Y; Zhao D; Fan L; Yu Z; Wang Y; Li Z; Zhang W; Bai Q; Yan Q; Guo Y; Wang Z; Guo S Hum Pathol; 2017 Jun; 64():213-221. PubMed ID: 28438623 [TBL] [Abstract][Full Text] [Related]
9. Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease? Hartmann S; Döring C; Jakobus C; Rengstl B; Newrzela S; Tousseyn T; Sagaert X; Ponzoni M; Facchetti F; de Wolf-Peeters C; Steidl C; Gascoyne R; Küppers R; Hansmann ML PLoS One; 2013; 8(11):e78812. PubMed ID: 24244368 [TBL] [Abstract][Full Text] [Related]
10. Macrophages in T cell/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotype. Hartmann S; Tousseyn T; Döring C; Flüchter P; Hackstein H; Herreman A; Ponzoni M; de Wolf-Peeters C; Facchetti F; Gascoyne RD; Küppers R; Steidl C; Hansmann ML Int J Cancer; 2013 Dec; 133(11):2609-18. PubMed ID: 23686423 [TBL] [Abstract][Full Text] [Related]
11. Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling. Tian X; Xu J; Fletcher C; Hornick JL; Dorfman DM Mod Pathol; 2018 Apr; 31(4):553-561. PubMed ID: 29327713 [TBL] [Abstract][Full Text] [Related]
12. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma. Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733 [TBL] [Abstract][Full Text] [Related]
13. Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities. Tousseyn TA; King RL; Fend F; Feldman AL; Brousset P; Jaffe ES Virchows Arch; 2023 Jan; 482(1):207-226. PubMed ID: 36274093 [TBL] [Abstract][Full Text] [Related]
14. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma. Wu D; Thomas A; Fromm JR Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540 [TBL] [Abstract][Full Text] [Related]
16. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma. Bakshi NA; Finn WG; Schnitzer B; Valdez R; Ross CW Arch Pathol Lab Med; 2007 May; 131(5):742-7. PubMed ID: 17488159 [TBL] [Abstract][Full Text] [Related]
17. Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases. Shi M; Shahsafaei A; Liu C; Yu H; Dorfman DM Leuk Lymphoma; 2015 Jul; 56(7):2087-91. PubMed ID: 25263318 [TBL] [Abstract][Full Text] [Related]
18. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Browne P; Petrosyan K; Hernandez A; Chan JA Am J Clin Pathol; 2003 Nov; 120(5):767-77. PubMed ID: 14608905 [TBL] [Abstract][Full Text] [Related]